Biomarkers for tyrosine kinase inhibitors in renal cell cancer

Nicholas Coupe; Michelle Harrison; Wei Chua; Paul de Souza

doi:10.3978/j.issn.2223-4683.2012.10.01

Biomarkers for tyrosine kinase inhibitors in renal cell cancer

Nicholas Coupe, Michelle Harrison, Wei Chua, Paul de Souza

Research output: Contribution to journal › Article › peer-review

Abstract

Renal cell carcinoma (RCC) is a common malignancy. In 2012, in the USA, there were 65,000 new cases and 13,500 disease-specific deaths. In the same year it was the 6th most common new cancer diagnosed. During the last 50 years, despite an increase in incidence, the mortality has fallen, a possible result of earlier detection and improvements in therapy.

Original language	English
Pages (from-to)	216-222
Number of pages	7
Journal	Translational Andrology and Urology
Volume	1
Issue number	4
DOIs	https://doi.org/10.3978/j.issn.2223-4683.2012.10.01
Publication status	Published - 2012

Open Access - Access Right Statement

Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/

Keywords

renal cell carcinoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3978/j.issn.2223-4683.2012.10.01

Cite this

@article{fae6b62512c44a29a2d60bf6d10290d2,

title = "Biomarkers for tyrosine kinase inhibitors in renal cell cancer",

abstract = "Renal cell carcinoma (RCC) is a common malignancy. In 2012, in the USA, there were 65,000 new cases and 13,500 disease-specific deaths. In the same year it was the 6th most common new cancer diagnosed. During the last 50 years, despite an increase in incidence, the mortality has fallen, a possible result of earlier detection and improvements in therapy.",

keywords = "renal cell carcinoma",

author = "Nicholas Coupe and Michelle Harrison and Wei Chua and {de Souza}, Paul",

year = "2012",

doi = "10.3978/j.issn.2223-4683.2012.10.01",

language = "English",

volume = "1",

pages = "216--222",

journal = "Translational Andrology and Urology",

issn = "2223-4683",

publisher = "AME Publishing Company",

number = "4",

}

TY - JOUR

T1 - Biomarkers for tyrosine kinase inhibitors in renal cell cancer

AU - Coupe, Nicholas

AU - Harrison, Michelle

AU - Chua, Wei

AU - de Souza, Paul

PY - 2012

Y1 - 2012

N2 - Renal cell carcinoma (RCC) is a common malignancy. In 2012, in the USA, there were 65,000 new cases and 13,500 disease-specific deaths. In the same year it was the 6th most common new cancer diagnosed. During the last 50 years, despite an increase in incidence, the mortality has fallen, a possible result of earlier detection and improvements in therapy.

AB - Renal cell carcinoma (RCC) is a common malignancy. In 2012, in the USA, there were 65,000 new cases and 13,500 disease-specific deaths. In the same year it was the 6th most common new cancer diagnosed. During the last 50 years, despite an increase in incidence, the mortality has fallen, a possible result of earlier detection and improvements in therapy.

KW - renal cell carcinoma

UR - http://hdl.handle.net/1959.7/uws:56111

U2 - 10.3978/j.issn.2223-4683.2012.10.01

DO - 10.3978/j.issn.2223-4683.2012.10.01

M3 - Article

SN - 2223-4683

VL - 1

SP - 216

EP - 222

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

IS - 4

ER -

Biomarkers for tyrosine kinase inhibitors in renal cell cancer

Abstract

Open Access - Access Right Statement

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this